Clinical trial of percutaneous radio frequency ablation therapy by two-step insertion method using VirtuTRAX™ instrument navigator

Teiji Kuzuya; Yoji Ishizu; Takurou Niinomi; Norihiro Imai; Kouichi Achiwa; Takahiro Arakawa; Keiichi Yamada; Satoshi Nakano; Takashi Honda; Kazuhiko Hayashi; Masatoshi Ishigami; Tetsuya Ishikawa; Isao Nakano; Yoshiaki Katano; Akihiro Itoh; Yoshiki Hirooka; Namiki Izumi; Hidemi Goto

doi:10.2957/kanzo.54.850

Clinical trial of percutaneous radio frequency ablation therapy by two-step insertion method using VirtuTRAX™ instrument navigator

Teiji Kuzuya, Yoji Ishizu, Takurou Niinomi, Norihiro Imai, Kouichi Achiwa, Takahiro Arakawa, Keiichi Yamada, Satoshi Nakano, Takashi Honda, Kazuhiko Hayashi, Masatoshi Ishigami, Tetsuya Ishikawa, Isao Nakano, Yoshiaki Katano, Akihiro Itoh, Yoshiki Hirooka, Namiki Izumi, Hidemi Goto

Research output: Contribution to journal › Article › peer-review

Abstract

We performed percutaneous radio frequency ablation (RFA) therapy by two-step insertion method using VirtuTRAX™ (GE Healthcare, USA) instrument navigator. Subjects were 16 patients (23 nodules) with hepatocellular carcinoma. VirtuTRAX™ position sensor was attached to the hilt of 14-gauge outer needle. In all cases, we could perform 17- gauge Cool-tip RFA without the positional gap between the virtual tract and the actual needle which was caused by the deflection of the needle. The reasons without causing the positional gap were that the outer needle was more rigid than Cool-tip needle, and that it was inserted using initial insertion of a 21-gauge guided needle. RFA by two-step insertion method using VirtuTRAX™ is suggested to be more safe and effective than conventional RFA.

Original language	English
Pages (from-to)	850-853
Number of pages	4
Journal	Acta Hepatologica Japonica
Volume	54
Issue number	12
DOIs	https://doi.org/10.2957/kanzo.54.850
Publication status	Published - 2013
Externally published	Yes

All Science Journal Classification (ASJC) codes

Hepatology

Access to Document

10.2957/kanzo.54.850

Cite this

Kuzuya, T., Ishizu, Y., Niinomi, T., Imai, N., Achiwa, K., Arakawa, T., Yamada, K., Nakano, S., Honda, T., Hayashi, K., Ishigami, M., Ishikawa, T., Nakano, I., Katano, Y., Itoh, A., Hirooka, Y., Izumi, N., & Goto, H. (2013). Clinical trial of percutaneous radio frequency ablation therapy by two-step insertion method using VirtuTRAX™ instrument navigator. Acta Hepatologica Japonica, 54(12), 850-853. https://doi.org/10.2957/kanzo.54.850

@article{2abdca22fa8b4592be410086629dc0ac,

title = "Clinical trial of percutaneous radio frequency ablation therapy by two-step insertion method using VirtuTRAX{\texttrademark} instrument navigator",

abstract = "We performed percutaneous radio frequency ablation (RFA) therapy by two-step insertion method using VirtuTRAX{\texttrademark} (GE Healthcare, USA) instrument navigator. Subjects were 16 patients (23 nodules) with hepatocellular carcinoma. VirtuTRAX{\texttrademark} position sensor was attached to the hilt of 14-gauge outer needle. In all cases, we could perform 17- gauge Cool-tip RFA without the positional gap between the virtual tract and the actual needle which was caused by the deflection of the needle. The reasons without causing the positional gap were that the outer needle was more rigid than Cool-tip needle, and that it was inserted using initial insertion of a 21-gauge guided needle. RFA by two-step insertion method using VirtuTRAX{\texttrademark} is suggested to be more safe and effective than conventional RFA.",

author = "Teiji Kuzuya and Yoji Ishizu and Takurou Niinomi and Norihiro Imai and Kouichi Achiwa and Takahiro Arakawa and Keiichi Yamada and Satoshi Nakano and Takashi Honda and Kazuhiko Hayashi and Masatoshi Ishigami and Tetsuya Ishikawa and Isao Nakano and Yoshiaki Katano and Akihiro Itoh and Yoshiki Hirooka and Namiki Izumi and Hidemi Goto",

year = "2013",

doi = "10.2957/kanzo.54.850",

language = "English",

volume = "54",

pages = "850--853",

journal = "Acta Hepatologica Japonica",

issn = "0451-4203",

publisher = "Japan Society of Hepatology",

number = "12",

}

Kuzuya, T, Ishizu, Y, Niinomi, T, Imai, N, Achiwa, K, Arakawa, T, Yamada, K, Nakano, S, Honda, T, Hayashi, K, Ishigami, M, Ishikawa, T, Nakano, I, Katano, Y, Itoh, A, Hirooka, Y, Izumi, N & Goto, H 2013, 'Clinical trial of percutaneous radio frequency ablation therapy by two-step insertion method using VirtuTRAX™ instrument navigator', Acta Hepatologica Japonica, vol. 54, no. 12, pp. 850-853. https://doi.org/10.2957/kanzo.54.850

TY - JOUR

T1 - Clinical trial of percutaneous radio frequency ablation therapy by two-step insertion method using VirtuTRAX™ instrument navigator

AU - Kuzuya, Teiji

AU - Ishizu, Yoji

AU - Niinomi, Takurou

AU - Imai, Norihiro

AU - Achiwa, Kouichi

AU - Arakawa, Takahiro

AU - Yamada, Keiichi

AU - Nakano, Satoshi

AU - Honda, Takashi

AU - Hayashi, Kazuhiko

AU - Ishigami, Masatoshi

AU - Ishikawa, Tetsuya

AU - Nakano, Isao

AU - Katano, Yoshiaki

AU - Itoh, Akihiro

AU - Hirooka, Yoshiki

AU - Izumi, Namiki

AU - Goto, Hidemi

PY - 2013

Y1 - 2013

N2 - We performed percutaneous radio frequency ablation (RFA) therapy by two-step insertion method using VirtuTRAX™ (GE Healthcare, USA) instrument navigator. Subjects were 16 patients (23 nodules) with hepatocellular carcinoma. VirtuTRAX™ position sensor was attached to the hilt of 14-gauge outer needle. In all cases, we could perform 17- gauge Cool-tip RFA without the positional gap between the virtual tract and the actual needle which was caused by the deflection of the needle. The reasons without causing the positional gap were that the outer needle was more rigid than Cool-tip needle, and that it was inserted using initial insertion of a 21-gauge guided needle. RFA by two-step insertion method using VirtuTRAX™ is suggested to be more safe and effective than conventional RFA.

AB - We performed percutaneous radio frequency ablation (RFA) therapy by two-step insertion method using VirtuTRAX™ (GE Healthcare, USA) instrument navigator. Subjects were 16 patients (23 nodules) with hepatocellular carcinoma. VirtuTRAX™ position sensor was attached to the hilt of 14-gauge outer needle. In all cases, we could perform 17- gauge Cool-tip RFA without the positional gap between the virtual tract and the actual needle which was caused by the deflection of the needle. The reasons without causing the positional gap were that the outer needle was more rigid than Cool-tip needle, and that it was inserted using initial insertion of a 21-gauge guided needle. RFA by two-step insertion method using VirtuTRAX™ is suggested to be more safe and effective than conventional RFA.

UR - http://www.scopus.com/inward/record.url?scp=84940303051&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940303051&partnerID=8YFLogxK

U2 - 10.2957/kanzo.54.850

DO - 10.2957/kanzo.54.850

M3 - Article

AN - SCOPUS:84940303051

VL - 54

SP - 850

EP - 853

JO - Acta Hepatologica Japonica

JF - Acta Hepatologica Japonica

SN - 0451-4203

IS - 12

ER -

Clinical trial of percutaneous radio frequency ablation therapy by two-step insertion method using VirtuTRAX™ instrument navigator

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this